Nib (CO-1686) or Erlotinib in Individuals Eith EGFR Mutant NSCLC Who
Nib (CO-1686) or Erlotinib in Sufferers Eith EGFR Mutant NSCLC That have Not Had Any Past EGFR Directed Therapy]; ClinicalTrials.gov identifier NCT02186301; and TIGER-X ; ClinicalTrials.gov NCT01526928) Ramucirumab; ongoing trials…